External quality assessment schemes for blood coagulation
The WHO EQAS for Blood Coagulation is distributed to over 160 laboratories in 29 WHO member states by the WHO Collaborating Centre based within the UK National External Quality Assessment Scheme (UKNEQAS) located at Royal Hallamshire Hospital, Sheffield, UK.
The purpose of the scheme is to assess laboratory capability to perform tests if blood coagulation and other tests of haemostasis. Each survey comprises samples for Prothrombin, Time Determination, Activated Partial Thromboplastin Time, Fibrinogen, FDP, Factor II, VII, IX, XII, VIII, Cassay, Von Willebrand Factor, Protein C, Protein S and Heparin among others.
The scheme offers support in the form of trouble-shooting for all participating laboratories.
Circonstances et modalités d’utilisation des tests d’infection récente pour estimer l’incidence de l’infection à HIV au niveau d’une population.
When and how to use assays for recent infection to estimate HIV incidence at a population level
HIV Rapid Assays: Operational Characteristics Report 16
- View all documents
- WHO Prequalification of Medicines, Diagnostics and Vaccines: 6th Consultative Meeting with Stakeholders, 4-5 April 2011
- WHO Technical Working Group Meeting on CD 4 Technologies,17 -19 November 2009
- WHO Technical Working Group Meeting on Prequalification of HIV Virological Technologies, 21-23 September 2009
- View all events